https://carolinaurologicresearchcenter.com/wp-content/uploads/WileyOnline.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2017-02-09 14:53:512017-02-09 14:53:51Clinical outcomes and survival surrogacy studies of prostate-specific antigen declines following enzalutamide in men with metastatic castration-resistant prostate cancer previously treated with docetaxel. – with Dr. Neal Shore, MD
Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-naïve...